05Y Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vivoryon Therapeutics NV

Watchlist Manager

Watchlist

Price: 1.165 EUR Market Closed

Market Cap: €30.4m

	Vivoryon Therapeutics NV F:05Y	DE
T	Tod's SpA DUS:TOB	IT
	OrganiGram Holdings Inc TSX:OGI	CA
T	Tod's SpA XMUN:TOB	IT
A	Adaro Energy Indonesia TBK PT SWB:A64	ID
B	BT Group PLC DUS:BTQ	UK
T	Tecan Group AG XMUN:TEN	CH
P	Perdoceo Education Corp SWB:CE1	US
A	Arabian Drilling Co SAU:2381	SA
V	Vinci SA SWB:SQU	FR
	Agora Inc NASDAQ:API	CN
V	Vodafone Group PLC F:VODJ	UK
	Premia Finance SpA Societa di Mediazione Creditizia F:81U	IT
B	Baltic Classifieds Group PLC LSE:BCG	UK
A	AIC Mines Ltd F:HLS	AU
	Tecnicas Reunidas SA OTC:TNISF	ES
	Storebrand ASA OSE:STB	NO
	Loews Corp NYSE:L	US
L	Laboratory Corporation of America Holdings F:LAB	US
	Bel Fuse Inc F:BF2A	US
C	CSW Industrials Inc F:UCI	US
	Cosmos Pharmaceutical Corp TSE:3349	JP
C	Caspian Sunrise PLC OTC:ROXIF	UK
K	KeyMed Biosciences Inc HKEX:2162	CN

Profitability Summary

Vivoryon Therapeutics NV's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

43%

Low Operating Margin

Strong 3Y Average Operating Margin

840%

Low Net Margin

Strong 3Y Average Net Margin

822%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

508%

Negative ROE

-145%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

2 009%

Declining ROIC

-3 165% > -3 588%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.